Insufficient scRNA-seq data for expression of PAFAH2 at single-cell level.
Insufficient scRNA-seq data for expression of PAFAH2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1336.99 | 966 / 966 | 100% | 25.20 | 527 / 527 |
prostate | 100% | 965.64 | 245 / 245 | 100% | 28.90 | 502 / 502 |
esophagus | 100% | 818.47 | 1443 / 1445 | 100% | 19.22 | 183 / 183 |
thymus | 100% | 1397.46 | 653 / 653 | 100% | 39.60 | 604 / 605 |
kidney | 100% | 1609.94 | 89 / 89 | 100% | 24.32 | 899 / 901 |
stomach | 100% | 1194.68 | 358 / 359 | 100% | 24.65 | 286 / 286 |
breast | 100% | 866.36 | 458 / 459 | 100% | 27.49 | 1117 / 1118 |
ovary | 99% | 575.31 | 179 / 180 | 100% | 16.50 | 430 / 430 |
pancreas | 100% | 2441.55 | 328 / 328 | 99% | 20.91 | 177 / 178 |
bladder | 100% | 830.33 | 21 / 21 | 99% | 18.85 | 501 / 504 |
uterus | 100% | 693.62 | 170 / 170 | 99% | 15.50 | 454 / 459 |
skin | 100% | 1292.27 | 1808 / 1809 | 99% | 19.22 | 466 / 472 |
lung | 98% | 827.20 | 569 / 578 | 100% | 20.86 | 1153 / 1155 |
brain | 98% | 470.78 | 2602 / 2642 | 100% | 13.56 | 703 / 705 |
liver | 100% | 1123.28 | 226 / 226 | 98% | 14.29 | 398 / 406 |
adrenal gland | 100% | 1121.24 | 257 / 258 | 96% | 13.80 | 221 / 230 |
spleen | 100% | 1131.90 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.71 | 1 / 1 |
adipose | 100% | 715.67 | 1201 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1506.55 | 799 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 522.59 | 1315 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.23 | 44 / 45 |
peripheral blood | 95% | 705.38 | 882 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 569.53 | 811 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 9.74 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 88% | 9.26 | 70 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006629 | Biological process | lipid metabolic process |
GO_0007596 | Biological process | blood coagulation |
GO_0016042 | Biological process | lipid catabolic process |
GO_0005737 | Cellular component | cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0003847 | Molecular function | 1-alkyl-2-acetylglycerophosphocholine esterase activity |
GO_0047179 | Molecular function | platelet-activating factor acetyltransferase activity |
GO_0005543 | Molecular function | phospholipid binding |
Gene name | PAFAH2 |
Protein name | Platelet-activating factor acetylhydrolase 2, cytoplasmic (EC 3.1.1.47) (PAF:lysophospholipid transacetylase) (PAF:sphingosine transacetylase) (Platelet-activating factor acetyltransferase PAFAH2) (EC 2.3.1.149) (Serine-dependent phospholipase A2) (SD-PLA2) (hSD-PLA2) 1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47) |
Synonyms | |
Description | FUNCTION: Catalyzes the hydrolyze of the acetyl group at the sn-2 position of platelet-activating factor (PAF) and its analogs, leading to their inactivation . Hydrolyzes propionyl and butyroyl moieties approximately half as effectively as PAF (By similarity). Also catalyzes transacetylation of the acetyl group from platelet-activating factor (PAF) to lysoplasmalogen and to sphingosine, producing plasmalogen analogs of PAF and N-acetylsphingosine (C2-ceramide) respectively. Has a marked selectivity for phospholipids with short acyl chains at the sn-2 position (By similarity). . |
Accessions | ENST00000439092.6 ENST00000374284.5 ENST00000374282.8 ENST00000441420.1 Q5SY01 Q5SY00 Q99487 |